Education and Training
Magnesium Sulfate vs Placebo for Placental Abruption
To evaluate the safety and efficacy of magnesium sulfate for preterm suspected abruption.
Stanford is currently not accepting patients for this trial.
Stanford Investigator(s):
Intervention(s):
- drug: Magnesium Sulfate
- other: Normal Saline
Eligibility
Inclusion Criteria:
- vaginal bleeding and contractions consistent with suspected placental abruption between
24 and 34 weeks gestation.
Exclusion Criteria:
- preterm labor, severe bleeding necessitating immediate delivery, maternal coagulopathy,
fetal distress
Ages Eligible for Study
18 Years - N/A
Genders Eligible for Study
Female
Not currently accepting new patients for this trial
Contact Information
Stanford University
School of Medicine
300 Pasteur Drive
Stanford,
CA
94305
Iris Colon, MD
(408) 855-5550
Not Recruiting